IVD Technology to launch first annual Virtual Conference and Tradeshow

NewsGuard 100/100 Score

IVD Technology, the only trade media brand designed exclusively for manufacturers of in vitro diagnostic products, today announced the launch of its first annual Virtual Conference and Tradeshow to be held on September 28, 2010. The Virtual Conference and Tradeshow will give in vitro diagnostic OEMs multi-media, real-time access to leading suppliers and event speakers from anywhere in the world, without the stress and cost of travel.

“This is a valuable tool for Canon Publishing, and we will closely monitor its effectiveness for possible use with other brands in our portfolio.”

As the only media provider dedicated exclusively to the in vitro diagnostics market, IVD Technology has the unique opportunity to be a bellwether for the market. Stephen Corrick, VP of Medical Device Media, said, "As leaders in the in vitro diagnostics space, our goal is to address the needs of this important audience across all relevant media channels. We had previously discussed an event of this nature as a someday project, but when our research showed that over 70% of IVD Technology's audience was interested in attending a virtual event we knew that someday had to be today."

Sponsors for IVD Technology's Virtual Conference and Tradeshow are Biosearch Technologies and G&L Precision Die Cutting, LLC. Participating speakers include:

  • Keynote speaker, Alberto Gutierrez, PhD, Director, OIVD
  • Peter Lea, PhD, Founder and Chief Science Officer, SQI Diagnostics Inc.
  • Robin, PhD, Professor of Pathology and Associate Director of Clinical Chemistry, University of Virginia
  • Damon Getman, PhD, Senior Staff Scientist, Gen-Probe Inc.

IVD Technology's Editor-in-Chief, Richard Park, commented, "The editorial team is thrilled to have a new media outlet to reach the in vitro diagnostics market. The experience and industry standing of each of our panelists augment the viability of this new medium to address the needs of our target audience. With the wide breadth of topics being covered - including regulation of IVDs, assay development, instrumentation and automation, and molecular diagnostics - this event is poised to be both an attention-getting and beneficial addition to IVD Technology's industry outreach."

Ron Wall, Senior Vice President for Publications at Canon, said that the virtual event technology provides a new channel for Canon's Publishing Division to provide value for IVD Technology's readers and advertisers. "This is a valuable tool for Canon Publishing, and we will closely monitor its effectiveness for possible use with other brands in our portfolio."

IVD Technology's Virtual Conference and Tradeshow platform was built on technology provided by Momentum Events. Stuart Bowen, President of Momentum Events, said, "We are extremely excited to be the enabling technology partner behind the IVD Technology Conference and Tradeshow. IVD Technology selected Momentum Events because, as a reseller of leading virtual event and stream media products including the expos2 Virtual-Expo platform, we could offer the best virtual event solution based on the objectives and budget of our client. IVD Technology has broken new ground with this event because no traditional trade show exists specifically to target manufacturers of in vitro diagnostic products and so a virtual event allows attendees to hear from leading experts, interact with sponsors and collect information, all without having to leave their office."

Source : Canon Communications

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study reveals lifestyle factors boosting IVF success